Molecular markers that are associated with monoclonal anti-PD-1 and anti-PD-L1 antibody treatment response are—PD-L1 expression, tumor mutational burden, tumor infiltrating lymphocytes, and soluble molecular factors (Figure 4A) [399,402]. Here, PDCD1 is linked to neoplasm.